Cargando…
Low‐dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity‐related chronic kidney disease
AIM: To determine, using a mouse model of obesity, whether low‐dose hydralazine prevents obesity‐related chronic kidney disease (CKD). METHODS: From 8 weeks of age, male C57BL/6 mice received a high‐fat diet (HFD) or chow, with or without low‐dose hydralazine (25 mg/L) in drinking water, for 24 week...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544807/ https://www.ncbi.nlm.nih.gov/pubmed/35635331 http://dx.doi.org/10.1111/dom.14778 |